|
|
|
|
|
|
| |
|
|
| |
Join Our Complimentary Webinar on
Thursday, May 11, 2017 at 9:00 AM EDT |
| |
|
|
|
| |
|
Celsis for Sterility:
Validating a 7-Day Direct
Inoculation Sterility Test
Using the Celsis Advance®
|
|
|
Using Charles River Celsis® ATP-bioluminescence detection, Novartis has successfully validated a direct inoculation rapid sterility assay, reducing the time-to-result to only 7 days.
Join Dr. David Roesti of Novartis as he discusses the validation of this method and its non-inferiority to compendial testing. He will also present examples of validation criteria, including the statistical analysis and ways to optimize the limit of detection.
|
Do you have a scheduling conflict?
Sign up even if you can't make it, we'll share the recording after.
|
| |
| Presenter Information |
| |
|
|
 |
|
David Roesti, PhD
Technical Steward, Microbiology, Manufacturing Science & Technology
Novartis Pharma Schweiz AG
|
|
| |
|
|
| Dr. Roesti is an expert in pharmaceutical biology and aseptic processes. He currently oversees the standards and processes to maintain existing strategies and implement innovative concepts for microbial control of the Novartis group's sterile and non-sterile drug products. |
| |
|
|
| |
| Webinar Details |
| |
Time: 9:00 AM EDT
Date: May 11, 2017
Duration: 1 Hour
Host: Charles River |
|
|
|
|
|
|
|
|
|
|
|
| |
© 2017 Charles River Laboratories International, Inc.
This email was sent to %%email%% by charlesriver@crl.com.
Charles River Laboratories | 1.877.274.8371 | 251 Ballardvale St. | Wilmington | MA | 01887 |
|
| |
|
|
|
